"Oncología en Jujuy: Tratamientos y contención integral para pacientes con enfermedad de cáncer."

During the past decade, ARS Médica conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ARS Médica" #1 collaborator was "Actoverco" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Innogene Kalbiotech Pte. Ltd" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "ARS Médica" are "Advanced Solid Tumor" (1 trials), "Biliary Tract Cancer" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Cholangiocarcinoma" (1 trials) and "Diffuse Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "ARS Médica" in a lesser frequency.

Most popular intervention types in "ARS Médica" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Niraparib" (2 trials), "Placebo" (2 trials), "Prednisone" (2 trials), "Abiraterone Acetate" (1 trials) and "Abiraterone acetate (AA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "ARS Médica" are 5 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "ARS Médica". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in ARS Médica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ARS Médica, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".